Stock Analysis
- Japan
- /
- Food and Staples Retail
- /
- TSE:9989
SundrugLtd Full Year 2024 Earnings: EPS Beats Expectations
SundrugLtd (TSE:9989) Full Year 2024 Results
Key Financial Results
- Revenue: JP¥751.8b (up 8.9% from FY 2023).
- Net income: JP¥29.1b (up 13% from FY 2023).
- Profit margin: 3.9% (up from 3.7% in FY 2023). The increase in margin was driven by higher revenue.
- EPS: JP¥249 (up from JP¥220 in FY 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
SundrugLtd EPS Beats Expectations
Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 1.5%.
Looking ahead, revenue is forecast to grow 5.9% p.a. on average during the next 3 years, compared to a 3.4% growth forecast for the Consumer Retailing industry in Japan.
Performance of the Japanese Consumer Retailing industry.
The company's shares are up 3.4% from a week ago.
Risk Analysis
Before you take the next step you should know about the 1 warning sign for SundrugLtd that we have uncovered.
Valuation is complex, but we're helping make it simple.
Find out whether SundrugLtd is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.
View the Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're helping make it simple.
Find out whether SundrugLtd is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.
View the Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About TSE:9989
SundrugLtd
Operates and manages drug stores and dispensing pharmacies in Japan.